News Montgomery County Council Passes Bill to Enhance Support for Small Businesses Engaged in Research and Development Expedited Bill 31-22 will alter eligibility requirements of the Small Business Innovation…Super UserDecember 5, 2022
News Polaris Genomics Seeks to Reveal Invisible Wounds Illumina Accelerator alum Polaris Genomics is investigating how genomics can help diagnose…Super UserDecember 5, 2022
News AstraZeneca to Acquire Neogene Therapeutics, Accelerating Ambition in Oncology Cell Therapy | Business Wire SANTA MONICA, Calif. & AMSTERDAM--(BUSINESS WIRE)--Neogene Therapeutics, Inc. (Neogene), a global clinical-stage…Super UserDecember 5, 2022
News NIH Wins Licensing Executive Society Deals of Distinction Award for WHO C-TAP Partnership | Technology Transfer The NIH Technology Transfer Program has won the Licensing Executive Society’s Deals…Super UserNovember 30, 2022
News Montgomery County and BioHealth Innovation, Inc. welcome Luis Gutierrez as an “Executive in Residence” to Help Grow County’s Biotech Industry (Updated 11/29) Updated 11/29 BioHealth Innovation, Inc. (BHI) and Montgomery County are pleased to…Super UserNovember 29, 2022
News Announcing Your 3rd Annual BioBuzz Awards Finalists · BioBuzz We’re excited to announce this year’s finalists for the third annual 2022…Super UserNovember 28, 2022
News Johns Hopkins Researchers Design ‘Prodrug’ That Targets Cancer Cells’ Big Appetite for Glutamine, Leaving Healthy Cells Unharmed Johns Hopkins Medicine researchers have revamped an anti-cancer drug to better target…Super UserNovember 28, 2022
News Haystack Oncology Inks Lease In Baltimore’s City Garage Biotechnology firm Haystack Oncology Inc. has signed a lease in the City Garage Science & Technology…Super UserNovember 28, 2022
News QIAGEN launches monkeypox test for NeuMoDx platform to fight global outbreak by boosting research and surveillance | Business Wire HILDEN, Germany & GERMANTOWN, Maryland--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard:…Super UserNovember 28, 2022
News MacroGenics Earns $60 Million Milestone with U.S. FDA Approval of Teplizumab ROCKVILLE, MD, Nov. 17, 2022 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company…Super UserNovember 21, 2022